SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CanaQuest Medical Corp. – ‘S-1’ on 1/24/17 – ‘ZIP’

On:  Tuesday, 1/24/17, at 6:50pm ET   ·   As of:  1/25/17   ·   Accession #:  1493152-17-779   ·   File #:  333-215685

Previous ‘S-1’:  ‘S-1/A’ on 10/7/16   ·   Next & Latest:  ‘S-1/A’ on 2/3/17   ·   1 Reference:  By:  SEC – ‘UPLOAD’ on 1/31/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/25/17  CanaQuest Medical Corp.           S-1         1/24/17   87:8.2M                                   M2 Compliance/FA

Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.03M 
 2: EX-5        Opinion of Counsel re: Legality                     HTML     30K 
 3: EX-17.1     Letter re: Departure of Director                    HTML     25K 
10: R1          Document and Entity Information                     HTML     38K 
11: R2          Condensed Interim Balance Sheets                    HTML     87K 
12: R3          Condensed Interim Balance Sheets (Parenthetical)    HTML     35K 
13: R4          Condensed Interim Statements of Operations          HTML     82K 
14: R5          Condensed Interim Statements of Stockholders'       HTML    105K 
                Equity (Deficiency)                                              
15: R6          Condensed Interim Statements of Cash Flows          HTML    122K 
16: R7          Nature of the Business and Going Concern            HTML     41K 
17: R8          Presentation of Financial Statements                HTML     36K 
18: R9          Summary of Significant Accounting Policies          HTML     54K 
19: R10         Equipment and Leasehold Improvements                HTML     52K 
20: R11         Intangible Assets                                   HTML     29K 
21: R12         Advances from Shareholders and Related Parties      HTML     30K 
22: R13         Term Loan                                           HTML     33K 
23: R14         Convertible Note                                    HTML     31K 
24: R15         Capital Stock                                       HTML    166K 
25: R16         Income Taxes                                        HTML     48K 
26: R17         Commitments and Contingencies                       HTML     63K 
27: R18         Related Party Transactions                          HTML     34K 
28: R19         Financial Instruments                               HTML     80K 
29: R20         Subsequent Event                                    HTML     37K 
30: R21         Summary of Significant Accounting Policies          HTML     87K 
                (Policies)                                                       
31: R22         Equipment and Leasehold Improvements (Tables)       HTML     49K 
32: R23         Capital Stock (Tables)                              HTML    114K 
33: R24         Income Taxes (Tables)                               HTML     47K 
34: R25         Commitments and Contingencies (Tables)              HTML     47K 
35: R26         Financial Instruments (Tables)                      HTML     64K 
36: R27         Nature of the Business and Going Concern (Details   HTML     30K 
                Narrative) (10-K)                                                
37: R28         Nature of the Business and Going Concern (Details   HTML     30K 
                Narrative) (10-Q)                                                
38: R29         Summary of Significant Accounting Policies          HTML     37K 
                (Details Narrative) (10-K)                                       
39: R30         Equipment and Leasehold Improvements (Details       HTML     29K 
                Narrative) (10-K)                                                
40: R31         Equipment and Leasehold Improvements - Schedule of  HTML     40K 
                Equipment and Leasehold Improvements (Details)                   
                (10-K)                                                           
41: R32         Equipment and Leasehold Improvements (Details       HTML     29K 
                Narrative) (10-Q)                                                
42: R33         Equipment and Leasehold Improvements - Schedule of  HTML     40K 
                Equipment and Leasehold Improvements (Details)                   
                (10-Q)                                                           
43: R34         Intangible Assets (Details Narrative) (10-K)        HTML     28K 
44: R35         Advances from Shareholders and Related Parties      HTML     49K 
                (Details Narrative) (10-K)                                       
45: R36         Advances from Shareholders and Related Parties      HTML     33K 
                (Details Narrative) (10-Q)                                       
46: R37         Term Loan (Details Narrative) (10-K)                HTML     52K 
47: R38         Term Loan (Details Narrative) (10-Q)                HTML     45K 
48: R39         Convertible Note (Details Narrative) (10-K)         HTML     54K 
49: R40         Capital Stock (Details Narrative) (10-K)            HTML    399K 
50: R41         Capital Stock - Summary of Warrants Outstanding     HTML     75K 
                (Details) (10-K)                                                 
51: R42         Capital Stock - Summary of Warrants Outstanding     HTML    174K 
                (Details) (10-K) (Parenthetical)                                 
52: R43         Capital Stock - Schedule of Warrant Activity        HTML     40K 
                (Details) (10-K)                                                 
53: R44         Capital Stock - Schedule of Option Activity         HTML     36K 
                (Details) (10-K)                                                 
54: R45         Capital Stock - Schedule of Stock Options           HTML     47K 
                Outstanding and Exercisable (Details) (10-K)                     
55: R46         Capital Stock (Details Narrative) (10-Q)            HTML    379K 
56: R47         Capital Stock - Schedule of Shares to be Issued     HTML     41K 
                (Details) (10-Q)                                                 
57: R48         Capital Stock - Summary of Warrants Outstanding     HTML     62K 
                (Details) (10-Q)                                                 
58: R49         Capital Stock - Summary of Warrants Outstanding     HTML    142K 
                (Details) (10-Q) (Parenthetical)                                 
59: R50         Capital Stock - Schedule of Warrant Activity        HTML     40K 
                (Details) (10-Q)                                                 
60: R51         Capital Stock - Schedule of Option Activity         HTML     36K 
                (Details) (10-Q)                                                 
61: R52         Capital Stock - Schedule of Stock Options           HTML     47K 
                Outstanding and Exercisable (Details) (10-Q)                     
62: R53         Income Taxes (Details Narrative) (10-K)             HTML     32K 
63: R54         Income Taxes - Schedule of Income Tax               HTML     44K 
                Reconciliation (Details) (10-K)                                  
64: R55         Income Taxes - Schedule of Deferred Taxe Assets     HTML     34K 
                and Liabilities (Details) (10-K)                                 
65: R56         Income Taxes - Schedule of Operating Loss Carry     HTML     41K 
                Forwards (Details) (10-K)                                        
66: R57         Income Taxes (Details Narrative) (10-Q)             HTML     29K 
67: R58         Commitments and Contingencies (Details Narrative)   HTML     76K 
                (10-K)                                                           
68: R59         Commitments and Contingencies - Schedule of Future  HTML     34K 
                Minimum Rental Payments for Operating Leases                     
                (Details) (10-K)                                                 
69: R60         Commitments and Contingencies - Schedule of         HTML     55K 
                Employment Agreements (Details) (10-K)                           
70: R61         Commitments and Contingencies (Details Narrative)   HTML    122K 
                (10-Q)                                                           
71: R62         Commitments and Contingencies - Schedule of Future  HTML     34K 
                Minimum Rental Payments for Operating Leases                     
                (Details) (10-Q)                                                 
72: R63         Commitments and Contingencies - Schedule of         HTML     55K 
                Employment Agreements (Details) (10-Q)                           
73: R64         Related Party Transactions (Details Narrative)      HTML     38K 
                (10-K)                                                           
74: R65         Related Party Transactions (Details Narrative)      HTML     34K 
                (10-Q)                                                           
75: R66         Financial Instruments (Details Narrative) (10-K)    HTML     63K 
76: R67         Financial Instruments - Fair Value of Financial     HTML     33K 
                Liabilities (Details) (10-K)                                     
77: R68         Financial Instruments - Changes in the Fair Value   HTML     41K 
                of Level 3 Financial Liabilities (Details) (10-K)                
78: R69         Financial Instruments - Estimated Fair Value        HTML     41K 
                Assumptions (Details) (10-K)                                     
79: R70         Financial Instruments (Details Narrative) (10-Q)    HTML     67K 
80: R71         Financial Instruments - Summary of Fair Value of    HTML     33K 
                Financial Liabilities (Details) (10-Q)                           
81: R72         Financial Instruments - Summary of Changes in the   HTML     34K 
                Fair Value of Level 3 Financial Liabilities                      
                (Details) (10-Q)                                                 
82: R73         Financial Instruments - Estimated Fair Value        HTML     41K 
                Assumptions (Details) (10-Q)                                     
83: R74         Subsequent Event (Details Narrative) (10-K)         HTML     89K 
84: R75         Subsequent Event (Details Narrative) (10-Q)         HTML     98K 
86: XML         IDEA XML File -- Filing Summary                      XML    165K 
85: EXCEL       IDEA Workbook of Financial Reports                  XLSX    108K 
 4: EX-101.INS  XBRL Instance -- adynf-20160930                      XML   1.88M 
 6: EX-101.CAL  XBRL Calculations -- adynf-20160930_cal              XML    161K 
 7: EX-101.DEF  XBRL Definitions -- adynf-20160930_def               XML    955K 
 8: EX-101.LAB  XBRL Labels -- adynf-20160930_lab                    XML   1.01M 
 9: EX-101.PRE  XBRL Presentations -- adynf-20160930_pre             XML   1.12M 
 5: EX-101.SCH  XBRL Schema -- adynf-20160930                        XSD    207K 
87: ZIP         XBRL Zipped Folder -- 0001493152-17-000779-xbrl      Zip    149K 


‘ZIP’   —   XBRL Zipped Folder — 0001493152-17-000779-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:adynf-20160930.xml
adynf-20160930.xsd
adynf-20160930_cal.xml
adynf-20160930_def.xml
adynf-20160930_lab.xml
adynf-20160930_pre.xml


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/17  SEC                               UPLOAD10/14/17    1:134K CanaQuest Medical Corp.
Top
Filing Submission 0001493152-17-000779   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 12:36:30.1pm ET